Rezultati - Andrea Corbacioglu

  • Showing 1 - 13 results of 13
Refine Results
  1. 1
    Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations

    Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations od Konstanze Döhner, Richard F. Schlenk, Marianne Habdank, Claudia Scholl, Frank G. Rücker, Andrea Corbacioglu, Lars Bullinger, Stefan Fröhling, Hartmut Döhner

    Izdano 2005
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    Prognostic impact of WT1 mutations in cytogenetically normal acute myeloid leukemia: a study of the German-Austrian AML Study Group

    Prognostic impact of WT1 mutations in cytogenetically normal acute myeloid leukemia: a study of the German-Austrian AML Study Group od Verena I. Gaidzik, Richard F. Schlenk, Simone Moschny, Annegret Becker, Lars Bullinger, Andrea Corbacioglu, Jürgen Krauter, Brigitte Schlegelberger, Arnold Ganser, Hartmut Döhner, Konstanze Döhner

    Izdano 2009
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia

    Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia od Richard F. Schlenk, Konstanze Döhner, Jürgen Krauter, Stefan Fröhling, Andrea Corbacioglu, Lars Bullinger, Marianne Habdank, Daniela Späth, Michael Morgan, Axel Benner, Brigitte Schlegelberger, Gerhard Heil, Arnold Ganser, Hartmut Döhner

    Izdano 2008
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    Prognostic Impact of Minimal Residual Disease in<i>CBFB-MYH11</i>–Positive Acute Myeloid Leukemia

    Prognostic Impact of Minimal Residual Disease in<i>CBFB-MYH11</i>–Positive Acute Myeloid Leukemia od Andrea Corbacioglu, Claudia Scholl, Richard F. Schlenk, Karina Eiwen, Juan Du, Lars Bullinger, Stefan Fröhling, Peter Reimer, Mathias Rummel, Hans-Günter Derigs, David Nachbaur, Jürgen Krauter, Arnold Ganser, Hartmut Döhner, Konstanze Döhner

    Izdano 2010
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  5. 5
    Gene-expression profiling identifies distinct subclasses of core binding factor acute myeloid leukemia

    Gene-expression profiling identifies distinct subclasses of core binding factor acute myeloid leukemia od Lars Bullinger, Frank G. Rücker, Stephan Kurz, Juan Du, Claudia Scholl, Sandrine Sander, Andrea Corbacioglu, Claudio Lottaz, Jürgen Krauter, Stefan Fröhling, Arnold Ganser, Richard F. Schlenk, Konstanze Döhner, Jonathan R. Pollack, Hartmut Döhner

    Izdano 2007
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  6. 6
    Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entity

    Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence... od Erdogan Taskesen, Lars Bullinger, Andrea Corbacioglu, Mathijs A. Sanders, Claudia Erpelinck-Verschueren, Bas J. Wouters, Sonja C. van der Poel-van de Luytgaarde, Frédérik Damm, Jürgen Krauter, Arnold Ganser, Richard F. Schlenk, Bob Löwenberg, Ruud Delwel, Hartmut Döhner, Peter J.M. Valk, Konstanze Döhner

    Izdano 2010
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  7. 7
    <i>RUNX1</i> Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and Clinical Analysis From the AML Study Group

    <i>RUNX1</i> Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and Clinical Analysis From the AML Study Group od Verena I. Gaidzik, Lars Bullinger, Richard F. Schlenk, Andreas Zimmermann, Jürgen Röck, Peter Paschka, Andrea Corbacioglu, Jürgen Krauter, Brigitte Schlegelberger, Arnold Ganser, Daniela Späth, Andrea Kündgen, Ingo G.H. Schmidt‐Wolf, Katharina S. Götze, David Nachbaur, Michael Pfreundschuh, Heinz A. Horst, Hartmut Döhner, Konstanze Döhner

    Izdano 2011
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  8. 8
    The value of allogeneic and autologous hematopoietic stem cell transplantation in prognostically favorable acute myeloid leukemia with double mutant CEBPA

    The value of allogeneic and autologous hematopoietic stem cell transplantation in prognostically favorable acute myeloid leukemia with double mutant CEBPA od Richard F. Schlenk, Erdogan Taskesen, Yvette van Norden, Jürgen Krauter, Arnold Ganser, Lars Bullinger, Verena I. Gaidzik, Peter Paschka, Andrea Corbacioglu, Gudrun Göhring, Andrea Kündgen, Gerhard Held, Katharina S. Götze, Edo Vellenga, Juergen Kuball, Urs Schanz, Jakob Passweg, Thomas Pabst, Johan Maertens, Gert J. Ossenkoppele, Ruud Delwel, Hartmut Döhner, Jan J. Cornelissen, Konstanze Döhner, Bob Löwenberg

    Izdano 2013
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  9. 9
    Clonal evolution patterns in acute myeloid leukemia with NPM1 mutation

    Clonal evolution patterns in acute myeloid leukemia with NPM1 mutation od Sibylle Cocciardi, Anna Dolnik, Silke Kapp‐Schwoerer, Frank G. Rücker, Susanne Lux, Tamara J. Blätte, Sabrina Skambraks, Jan Krönke, Florian H. Heidel, Tina M. Schnöder, Andrea Corbacioglu, Verena I. Gaidzik, Peter Paschka, Veronica Teleanu, Gudrun Göhring, Felicitas Thol, Michael Heuser, Arnold Ganser, Daniela Weber, Eric Sträng, Hans A. Kestler, Hartmut Döhner, Lars Bullinger, Konstanze Döhner

    Izdano 2019
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  10. 10
    Genomic heterogeneity in core-binding factor acute myeloid leukemia and its clinical implication

    Genomic heterogeneity in core-binding factor acute myeloid leukemia and its clinical implication od Nikolaus Jahn, Tobias Terzer, Eric Sträng, Anna Dolnik, Sibylle Cocciardi, Ekaterina Panina, Andrea Corbacioglu, Julia Herzig, Daniela Weber, Anika Schrade, Katharina S. Götze, Thomas Schröder, Michael Lübbert, Dominique Wellnitz, Elisabeth Koller, Richard F. Schlenk, Verena I. Gaidzik, Peter Paschka, Frank G. Rücker, Michael Heuser, Felicitas Thol, Arnold Ganser, Axel Benner, Hartmut Döhner, Lars Bullinger, Konstanze Döhner

    Izdano 2020
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  11. 11
    Monitoring of Minimal Residual Disease in <i>NPM1</i>-Mutated Acute Myeloid Leukemia: A Study From the German-Austrian Acute Myeloid Leukemia Study Group

    Monitoring of Minimal Residual Disease in <i>NPM1</i>-Mutated Acute Myeloid Leukemia: A Study From the German-Austrian Acute Myeloid Leukemia Study Group od Jan Krönke, Richard F. Schlenk, Kai‐Ole Jensen, Florian Tschürtz, Andrea Corbacioglu, Verena I. Gaidzik, Peter Paschka, Shiva Onken, Karina Eiwen, Marianne Habdank, Daniela Späth, Michael Lübbert, Mohammed Wattad, Thomas Kindler, Helmut R. Salih, Gerhard Held, David Nachbaur, Marie von Lilienfeld‐Toal, Ulrich Germing, Detlef Haase, H.‐G. Mergenthaler, Jürgen Krauter, Arnold Ganser, Gudrun Göhring, Brigitte Schlegelberger, Hartmut Döhner, Konstanze Döhner

    Izdano 2011
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  12. 12
    Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study Group

    Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study Group od Frank G. Rücker, Mridul Agrawal, Andrea Corbacioglu, Daniela Weber, Silke Kapp‐Schwoerer, Verena I. Gaidzik, Nikolaus Jahn, Thomas Schroeder, Mohammed Wattad, Michael Lübbert, Elisabeth Koller, Thomas Kindler, Katharina S. Götze, Mark Ringhoffer, Jörg Westermann, Walter Fiedler, Heinz A. Horst, Richard Greil, Roland Schroers, Karin Mayer, Thomas Heinicke, Jürgen Krauter, Richard F. Schlenk, Felicitas Thol, Michael Heuser, Arnold Ganser, Lars Bullinger, Peter Paschka, Hartmut Döhner, Konstanze Döhner

    Izdano 2019
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  13. 13
    Impact of gemtuzumab ozogamicin on MRD and relapse risk in patients with <i>NPM1</i>-mutated AML: results from the AMLSG 09-09 trial

    Impact of gemtuzumab ozogamicin on MRD and relapse risk in patients with <i>NPM1</i>-mutated AML: results from the AMLSG 09-09 trial od Silke Kapp‐Schwoerer, Daniela Weber, Andrea Corbacioglu, Verena I. Gaidzik, Peter Paschka, Jan Krönke, Frauke Theis, Frank G. Rücker, Maria‐Veronica Teleanu, Ekaterina Panina, Nikolaus Jahn, Julia Herzig, Lena Kubanek, Anika Schrade, Gudrun Göhring, Walter Fiedler, Thomas Kindler, Thomas Schroeder, Karin Mayer, Michael Lübbert, Mohammed Wattad, Katharina S. Götze, Heinz A. Horst, Elisabeth Koller, Gerald Wulf, Jan Schleicher, Martin Bentz, Jürgen Krauter, Lars Bullinger, Julia Krzykalla, Axel Benner, Richard F. Schlenk, Felicitas Thol, Michael Heuser, Arnold Ganser, Hartmut Döhner, Konstanze Döhner

    Izdano 2020
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: